热门资讯> 正文
默克集团公布第二季度业绩
2025-08-07 17:25
- Merck KGaA press release (OTCPK:MKGAF): Q2 GAAP EPS of €1.50.
- Revenue of €5.26B (-1.7% Y/Y).
- Merck refined its existing guidance for the full year. The company narrowed the expected organic sales growth range for the Group to 2% to 5% (previously 2% to 6%). For EBITDA pre, Merck raised its guidance and now expects organic growth of 4% to 8% (previously 2% to 7%). This change was driven by positive guidance adjustments for Life Science and Healthcare as well as high cost discipline in all business sectors.
More on Merck KGaA
- Merck KGaA: The Undervaluation Is Now Close To 13-Year Lows
- Merck KGaA 2025 Q1 - Results - Earnings Call Presentation
- Merck KGaA (MKGAF) Q1 2025 Earnings Call Transcript
- Merck KGaA gets EU nod for genetic disorder therapy
- Merck KGaA Non-GAAP EPS of €2.12, revenue of €5.28B; updates FY25 outlook
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。